Pacific Biosciences Of California (PACB)
Stock-Based Compensation
$13.72M
Quarterly · Period ending: · USD
PACB Stock-Based Compensation
Latest reported$13.72Mperiod ending
Latest reported$13.72Mperiod ending
PACB Quarterly Stock-Based Comp ($977.00K → $13.72M)
Quarterly stock-based compensation
High-resolution chart · PNG
PACB stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 13,722,000 | |
| 0 | |
| 9,588,000 | |
| 0 | |
| 0 | |
| 9,201,000 | |
| 16,033,000 | |
| 18,259,000 | |
| 17,219,000 | |
| 19,525,000 | |
| 16,584,000 | |
| 19,691,000 | |
| 0 | |
| 17,952,000 | |
| 17,955,000 | |
| 0 | |
| 0 | |
| 0 | |
| 18,938,000 | |
| 0 | |
| 15,805,000 | |
| 10,165,000 | |
| 5,275,000 | |
| 4,992,000 | |
| 3,234,000 | |
| 4,032,000 | |
| 3,869,000 | |
| 4,062,000 | |
| 4,089,000 | |
| 4,381,000 | |
| 7,522,000 | |
| 5,125,000 | |
| 5,224,000 | |
| 5,282,000 | |
| 5,390,000 | |
| 4,968,000 | |
| 5,010,000 | |
| 4,985,000 | |
| 4,836,000 | |
| 5,107,000 | |
| 5,038,000 | |
| 4,581,000 | |
| 4,027,000 | |
| 3,238,000 | |
| 3,320,000 | |
| 3,255,000 | |
| 2,999,000 | |
| 2,452,000 | |
| 2,222,000 | |
| 2,270,000 | |
| 2,544,000 | |
| 2,171,000 | |
| 2,444,000 | |
| 2,746,000 | |
| 2,547,000 | |
| 2,388,000 | |
| 2,583,000 | |
| 2,187,000 | |
| 3,284,000 | |
| 2,989,000 | |
| 3,007,000 | |
| 3,104,000 | |
| 3,422,000 | |
| 2,263,000 | |
| 1,906,000 | |
| 2,099,000 | |
| 1,017,000 | |
| 977,000 |